|
Read more ›› |
By: GlobenewsWire - 30 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 30 Nov 2020
|
Related companies:
Gain Therapeutics, Barcelona |
Gain Therapeutics SA |
|
|
SEOUL, South Korea, Nov. 24, 2020 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today, in collaboration with the Seoul Metropolitan Government (SMG) and Korea Health Industry Development Institute (KHIDI), named DC Medical and deepmedi as awardees of the Read more ›› |
By: PR Newswire Association LLC. - 25 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 23 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 23 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 23 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 18 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 18 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 18 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 17 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 16 Nov 2020
|
|
|
SHANGHAI, Nov. 16, 2020 /PRNewswire/ -- Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate. With promising preliminary... Read more ›› |
By: PR Newswire Association LLC. - 16 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 14 Nov 2020
|
|
|
BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for in Asia 2020 Award' by HR Asia on 16(th) October 2020. Read more ›› |
By: PR Newswire Association LLC. - 12 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 11 Nov 2020
|
Related companies:
Oryzon Genomics, S.A. |
Oryzon Genomics |
|
|
Read more ›› |
By: GlobenewsWire - 11 Nov 2020
|
|
|
Read more ›› |
By: GlobenewsWire - 10 Nov 2020
|
Related companies:
Oryzon Genomics, S.A. |
Oryzon Genomics |
|
|
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica... Read more ›› |
By: PR Newswire Association LLC. - 10 Nov 2020
|
|
|
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
By: PR Newswire Association LLC. - 09 Nov 2020
|
|
|
|